Go to the CREATIC websiteCREATIC websiteWebsite
MEDICA 2026 16–19 Nov · Düsseldorf Hall 1 / Stand F24
Book a meeting

Centre of Excellence CREATIC · Masaryk University, Faculty of Medicine

From lab
to patient
access

Your partner for the entire ATMP journey

Why talk to CREATIC at MEDICA

A research result
is not yet a treatment

Advanced therapy medicinal products (ATMPs) need far more than good science. Manufacturing, quality, regulation, clinical evidence and reimbursement all have to be planned early, and they rarely sit under one roof. CREATIC connects these steps in one collaborative environment in Brno, Czech Republic.

You are developing a cell or gene therapy

And need support with strategy, process development, GMP manufacturing of investigational products, regulatory planning or a clinical trial.

You build technologies for advanced therapies

Cell processing, manufacturing, quality control, diagnostics or data solutions, and you are looking for an academic GMP environment to collaborate with.

You plan clinical research in Central Europe

Through CZECRIN, the national clinical research infrastructure, you reach a coordinated network of faculty hospitals with one point of contact.

You are a biotech, pharma company or start-up

Engage us for one specialised service, a defined work package or an integrated programme across several stages.

You are an academic team or hospital

Looking for a partner to move a promising concept towards the clinic, or for joint research and training.

You are an investor or partnership lead

Interested in technology transfer, intellectual assets and partnerships in the Central European advanced-therapy ecosystem.

Make the meeting count

When you book, tell us briefly about your project: product type and indication, development stage and what you need next. We will bring the right people from our team to the stand.

Book a meeting

One partner across the ATMP lifecycle

The entire
ATMP journey.
Connected.

Developing an ATMP requires multiple highly specialised capabilities. CoE CREATIC brings them together in one collaborative environment. Follow the line from the first idea to patient access, or jump straight to the stage you need.

01

DISCOVER

ATMP Strategy & Translational Development

Start with the right development pathway

Early decisions can determine whether an innovative therapy can ultimately be manufactured, clinically evaluated, approved and made accessible to patients.

Product and development strategy

  • Initial ATMP concept assessment and unmet medical need
  • Development pathway and Product Development Plan
  • Milestones, risk identification and gap analysis
  • Scientific and translational consultation

Preclinical and translational strategy

  • Relevant experimental models and functional validation
  • Advanced genomic and molecular approaches
  • Biomarker and translational endpoint strategy
  • Preparation for the transition into clinical development

02

DEVELOP

Process Development & Technology Transfer

From a lab protocol to a controlled process

Translating scientific concepts and laboratory protocols into viable product and manufacturing strategies.

Process

  • Transfer of laboratory protocols into a controlled, GMP-ready process
  • Scale-up and scale-out
  • Raw materials strategy

Quality by design

  • Critical quality attributes and in-process controls
  • Analytical methods
  • Release strategy

03

MAKE

GMP Manufacturing & Quality Control · CREProFa

Clinical-grade manufacturing and quality control

The CREATIC Production Facility (CREProFa) provides specialised infrastructure for manufacturing investigational advanced therapies within its authorised scope.

Capabilities

  • Aseptic processing
  • Cell manipulation and expansion
  • Gene modification
  • Cryopreservation
  • Quality control, including sterility testing

Units

  • ACIU: Advanced Cell Immunotherapy Unit
  • GATU: Gene Advanced Therapy Unit
  • BiGU: Biotechnology GMP Unit
  • QC and R&D laboratories

04

NAVIGATE

Regulatory Affairs & Quality Strategy

Regulation planned in, not added on

Integrated regulatory strategy from early development through clinical development and beyond.

Regulatory strategy

  • Regulatory gap analysis and roadmaps
  • Preparation for interactions with authorities
  • Clinical trial, ATMP and GMO requirements
  • Hospital exemption pathway

Quality

  • Quality management systems
  • CAPA
  • Alignment of quality, regulatory and clinical requirements

05

TEST

Clinical Development & Clinical Trials · with CZECRIN

From protocol to first patient

Study design, regulatory submissions, trial management and access to clinical research infrastructure through CZECRIN, part of CREATIC.

Design and set-up

  • Study design, protocol and biostatistics
  • Regulatory and ethics submissions
  • Site feasibility and selection

Conduct

  • Sponsor support and project management
  • Monitoring
  • Pharmacovigilance and data management

06

CONNECT

Clinical Network & Access to Patients

The right centres and investigators

Access to investigators, specialised hospitals and patient populations through CZECRIN and European networks.

Network

  • Clinical trial units in university hospitals
  • Disease-oriented networks (DONETs)
  • Experienced investigators

How we help

  • Matching your study with suitable sites
  • One point of contact for the national network
  • Links to European clinical research infrastructure

07

PROVE

Data, Biostatistics & Pharmacovigilance

Evidence that holds up

Data management, biostatistics, pharmacovigilance, real-world evidence and evidence generation.

Data

  • Clinical databases and registries
  • FAIR data management
  • Bioinformatics
  • Real-world data and real-world evidence

Statistics and safety

  • Statistical analysis plans
  • SAE and SUSAR handling
  • EudraVigilance reporting

08

ACCESS

HTA, Pharmacoeconomics & Patient Access

Beyond regulatory approval

An approved therapy still has to reach patients. We help plan the evidence and strategy that payers and health systems need.

Health economics

  • Cost-effectiveness analyses
  • Evidence for health technology assessment

Access strategy

  • Market-access strategy
  • Preparing payer dialogue
  • Sustainable financing models

Across the whole journey

Turning results into value and skills

Partner

Valorisation, Partnerships & Open Access

Support for intellectual assets, technology transfer and partnerships, so that research results can become sustainable value.

  • Technology transfer and IP strategy
  • Freedom-to-operate and trademarks
  • Business development and partnership building

Learn

Education & Training

Training for researchers, clinicians and developers, delivered by CREATIC together with CZECRIN.

  • Eight micro-certified courses in advanced therapies
  • Interdisciplinary topics across the ATMP lifecycle
  • Clinical research training through CZECRIN Academy
Cover of the CREATIC brochure From lab to patient access

Brochure

All our services
in one brochure

The online brochure From lab to patient access takes you through the whole ATMP journey and every CREATIC service, with contacts for each stage. Read it before your meeting at MEDICA or share it with your team.

Read the brochure creatic.muni.cz/brochure

One journey.
Multiple entry points.

You do not need to commit to the whole journey. Start where you are.

A

Consultation

Talk through your concept, gaps and next steps.

B

Single service

One specialised service, for example a regulatory gap analysis.

C

Development work package

A defined package with clear deliverables.

D

Infrastructure access

Access to specialised facilities and expertise.

E

Joint R&D

Collaborative research and development projects.

F

Clinical collaboration

Trials and studies with CZECRIN and partner hospitals.

G

Integrated programme

Several stages of the ATMP lifecycle, coordinated.

→

Not sure where you fit?

Book a meeting at Hall 1 / F24 and we will find the right entry point together.

What has happened this year

2026 at CREATIC

All News & Insights on creatic.muni.cz

CZECRIN: access to patients

Patients waiting
for your trial

CZECRIN, the Czech Clinical Research Infrastructure Network, is designated by the Ministry of Health as the national infrastructure supporting clinical research in the Czech Republic. All faculty hospitals in the country work together in one network, with one point of contact.

CZECRIN is the Czech node of ECRIN-ERIC and part of the Centre of Excellence CREATIC. More for sponsors at czecrin.cz

CREATIC and CZECRIN sign at the CREATIC premises in Brno
17

clinical centres: 11 faculty hospitals and 6 specialised institutes

12

disease-oriented networks (DONETs)

15,000+

patients in disease registries (as of 2024)

10+

years of history, with the tenth anniversary in 2024

Our partners in consortium

Built with European partners

Masaryk University has established a partnership with the Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig University and the University of Copenhagen to build an R&D centre of excellence focused on advanced therapy medicinal products.

Fraunhofer IZI

Strategic partner in particular for the research and development of cell and gene therapies.

Leipzig University

Key partner contributing expertise in cutting-edge research, education and innovation.

University of Copenhagen

Expertise in social sciences and humanities, biomedical law, ethics and data protection.

For you at the stand

Meet our team in Hall 1 / F24

Jiří Deml

Jiří Deml, MD

Head of Strategy & Business Development Division

Regina Demlová

Assoc. Prof. Regina Demlová

Director of CoE CREATIC

Lenka Zdražilová Dubská

Prof. Lenka Zdražilová Dubská

Head of CREATIC Production Facility

Marie Mlnaříková

Marie Mlnaříková, PhD

Researcher / GMP Quality Control Operator

Gabriela Fialová

Gabriela Fialová

Project Coordinator

Find us

Visit us at MEDICA

Stand

Hall 1 / F24

Show on the hall plan ↗

When

16–19 Nov

2026 · Opening hours ↗

Where

Düsseldorf

Messe Düsseldorf
Stockumer Kirchstraße 61, 40474 Düsseldorf

Let’s talk

Let’s move
your ATMP
forward

creatic@med.muni.cz

MEDICA meetings: Gabriela Fialová
gabriela.fialova@med.muni.cz · +420 770 381 269

Brochure: creatic.muni.cz/brochure

Masaryk University, Faculty of Medicine
Kamenice 5, 625 00 Brno, Czech Republic

Book a meeting at MEDICA